Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial

Paul M. Ridker; Eleanor Danielson; Francisco A.H. Fonseca; Jacques Genest; Antonio M. Gotto; John J.P. Kastelein; Wolfgang Koenig; Peter Libby; Alberto J. Lorenzatti; Jean G. MacFadyen; Børge G. Nordestgaard; James Shepherd; James T. Willerson; Robert J. Glynn

doi:10.1097/01.ogx.0000358018.78512.a1

Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial

Paul M. Ridker, Eleanor Danielson, Francisco A.H. Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. MacFadyen, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	596-597
Number of pages	2
Journal	Obstetrical and Gynecological Survey
Volume	64
Issue number	9
DOIs	https://doi.org/10.1097/01.ogx.0000358018.78512.a1
State	Published - Sep 2009

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/01.ogx.0000358018.78512.a1

Cite this

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Glynn, R. J. (2009). Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial. Obstetrical and Gynecological Survey, 64(9), 596-597. https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial. / Ridker, Paul M.; Danielson, Eleanor; Fonseca, Francisco A.H. et al.
In: Obstetrical and Gynecological Survey, Vol. 64, No. 9, 09.2009, p. 596-597.

Research output: Contribution to journal › Comment/debate › peer-review

Ridker, PM, Danielson, E, Fonseca, FAH, Genest, J, Gotto, AM, Kastelein, JJP, Koenig, W, Libby, P, Lorenzatti, AJ, MacFadyen, JG, Nordestgaard, BG, Shepherd, J, Willerson, JT & Glynn, RJ 2009, 'Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial', Obstetrical and Gynecological Survey, vol. 64, no. 9, pp. 596-597. https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP et al. Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial. Obstetrical and Gynecological Survey. 2009 Sep;64(9):596-597. doi: 10.1097/01.ogx.0000358018.78512.a1

Ridker, Paul M. ; Danielson, Eleanor ; Fonseca, Francisco A.H. et al. / Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin : A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial. In: Obstetrical and Gynecological Survey. 2009 ; Vol. 64, No. 9. pp. 596-597.

@article{fe7a13c7c47f45fdae0b4db5619aaf15,

title = "Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial",

author = "Ridker, {Paul M.} and Eleanor Danielson and Fonseca, {Francisco A.H.} and Jacques Genest and Gotto, {Antonio M.} and Kastelein, {John J.P.} and Wolfgang Koenig and Peter Libby and Lorenzatti, {Alberto J.} and MacFadyen, {Jean G.} and Nordestgaard, {B{\o}rge G.} and James Shepherd and Willerson, {James T.} and Glynn, {Robert J.}",

year = "2009",

month = sep,

doi = "10.1097/01.ogx.0000358018.78512.a1",

language = "English (US)",

volume = "64",

pages = "596--597",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

TY - JOUR

T1 - Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin

T2 - A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial

AU - Ridker, Paul M.

AU - Danielson, Eleanor

AU - Fonseca, Francisco A.H.

AU - Genest, Jacques

AU - Gotto, Antonio M.

AU - Kastelein, John J.P.

AU - Koenig, Wolfgang

AU - Libby, Peter

AU - Lorenzatti, Alberto J.

AU - MacFadyen, Jean G.

AU - Nordestgaard, Børge G.

AU - Shepherd, James

AU - Willerson, James T.

AU - Glynn, Robert J.

PY - 2009/9

Y1 - 2009/9

UR - http://www.scopus.com/inward/record.url?scp=73249115586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73249115586&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000358018.78512.a1

DO - 10.1097/01.ogx.0000358018.78512.a1

M3 - Comment/debate

AN - SCOPUS:73249115586

SN - 0029-7828

VL - 64

SP - 596

EP - 597

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 9

ER -

Reduction in C-reactive protein and low-density lipoprotein cholesterol and cardiovascular event rates after initiation of rosuvastatin: A prospective study of the justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this